Insights

Tax tips, options trading ideas, and market takes — updated regularly.

filtered by tagclear

Options Strategies Market Commentary
Eli Lilly's $3.8B AtaiBeckley Buyout Is Actually Two Trades in One

AtaiBeckley shareholders vote September 8 on Eli Lilly's buyout. The deal pairs a hard $6.75 cash floor with a separate, much longer-dated bet on drug approvals — and the two pieces trade nothing alike.

August 11, 2026 ET